Zura Bio Statistics
Zura Bio (94E) Stock Statistics & Valuation Metrics
Total Valuation
Zura Bio has a market cap or net worth of EUR 108.35M. The enterprise value is EUR 343.63M.
- Market Cap
- EUR 108.35M
- Enterprise Value
- EUR 343.63M
Share Statistics
Zura Bio has 96,325,410 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 96,325,410
- Owned by Insiders
- 8.13%
- Owned by Institutions
- 18.32%
Financial Efficiency
Zura Bio’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -74.11%.
- Return on Equity (ROE)
- -0.68
- Return on Assets (ROA)
- -0.60
- Return on Invested Capital (ROIC)
- -74.11%
- Return on Capital Employed (ROCE)
- -0.74
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.72M
- Employee Count
- 40
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Zura Bio is -1.11. Zura Bio’s PEG ratio is 0.02.
- PE Ratio
- -1.11
- PS Ratio
- 0.00
- PB Ratio
- 0.89
- Price to FCF
- -1.46
- Price to Operating Cash Flow
- -1.94
- PEG Ratio
- 0.02
Income Statement
In the last 12 months, Zura Bio had revenue of 0 and earned -68.65M in profits. Earnings per share was -1.06.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -75.25M
- Pretax Income
- -68.65M
- Net Income
- -68.65M
- EBITDA
- -68.60M
- Earnings Per Share (EPS)
- -1.06
Cash Flow
In the last 12 months, operating cash flow was -81.60M and capital expenditures -90,000, giving a free cash flow of -81.69M billion.
- Operating Cash Flow
- -81.60M
- Free Cash Flow
- -81.69M
- Free Cash Flow per Share
- -0.64
Dividends & Yields
Zura Bio pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -68.39%
- Earnings Yield
- -59.06%
Stock Price Statistics
- Beta
- 0.91
- 52-Week Price Change
- -71.86%
- 50-Day Moving Average
- 3.74
- 200-Day Moving Average
- 4.38
- Relative Strength Index (RSI)
- 27.28
- Average Volume (3m)
- 810
Important Dates
Zura Bio upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 27, 2026
- Next Earnings Date
- Mar 31, 2027
- Ex-Dividend Date
- ―
Financial Position
Zura Bio as a current ratio of 9.05, with Debt / Equity ratio of 0.00%
- Current Ratio
- 9.05
- Quick Ratio
- 9.05
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.59
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Zura Bio has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Zura Bio EV to EBITDA ratio is 0.72, with an EV/FCF ratio of 0.83.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.72
- EV to Free Cash Flow
- 0.83
- EV to Operating Cash Flow
- 0.84
Balance Sheet
Zura Bio has EUR 187.65M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 187.65M billion.
- Cash & Marketable Securities
- EUR 187.65M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 187.65M
- Net Cash Per Share
- EUR 1.95
- Tangible Book Value Per Share
- EUR 1.39
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Zura Bio is EUR 9.68, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 9.68
- Price Target Upside
- 763.95% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 6
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -68.00%
Scores
- Smart Score
- 2
- AI Score
- ―

